Clinical Trials Logo

Clinical Trial Summary

This will be a prospective, multicentre study conducted to evaluate the diagnostic accuracy of two TB breath-based technologies independently of the manufacturers. Assay error and failure rates and device operational characteristics will also be assessed during this study. Participants will be enrolled in this study in line with FIND sample banking activities. Results from index tests will not be used to make clinical decisions. Participation in this study will not alter the standard of care.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03025516
Study type Observational
Source Find
Contact Sonia Arafah
Phone +41 (22) 710 05 90
Email sonia.arafah@finddx.org
Status Recruiting
Phase N/A
Start date May 29, 2017
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT00933790 - Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis Phase 3
Completed NCT04645836 - Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'. N/A
Recruiting NCT06058299 - Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis Phase 2
Completed NCT03722472 - Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults Phase 1
Completed NCT03678688 - A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis Phase 1/Phase 2
Completed NCT00212550 - Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb N/A
Completed NCT02961569 - Comparison Between Two Strategies for the Diagnosis of TB N/A
Recruiting NCT05426720 - Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
Recruiting NCT04264221 - Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging N/A
Active, not recruiting NCT05221502 - Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB Phase 2